The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
00
Short Talk: The Next Generation Diarylquinoline TBAJ 587 has Superior Efficacy Against, and Restricts Selection of, Bedaquiline Resistant Rv0678 Mutants in a Mouse Model of Tuberculosis